Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 4

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
ance of common stock from vesting of - restricted stock units 
     3,873  
     4  
     (4) 
     -  
     -  
     -  
     -  
     - 

    Net loss 
     -  
     -  
     -  
     -  
     -  
     -  
     (10,710,464) 
     (10,710,464)

    Relcassification of unrealized gains on available for sale investments upon settlement 
     -  
     -  
     -  
     -  
     -  
     (176,591) 
     -  
     (176,591)

    Balance, September 30, 2023 
     3,692,276  
     3,690  
     319,480,409  
     (2,288) 
     (2) 
     -  
     (311,936,169) 
     7,547,928 

    Stock-based compensation - stock options 
     -  
     -  
     619,701  
     -  
     -  
     -  
     -  
     619,701 

    Stock-based compensation - restricted stock units 
     -  
     -  
     303,173  
     -  
     -  
     -  
     -  
     303,173 

    Proceeds from issuance of common stock, net of costs of  $258,254 
     290,090  
     290  
     7,421,588  
     -  
     -  
     -  
     -  
     7,421,878 

    Issuance of common stock from vesting of - restricted stock units 
     4,305  
     4  
     (4) 
     -  
     -  
     -  
     -  
     - 

    Net loss 
     -  
     -  
     -  
     -  
     -  
     -